KRT-24033-47060 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-31
Dose 1 — Pfizer-BioNTech
Co-administered: Do not remember
2021-09-23
Registered in v-safe
2021-09-23
Dose 2 — Pfizer-BioNTech
Co-administered: Do not remember
2021-09-23
Health check-in — day 0, dose 2
Feeling: Fair · Site: Itching · Fatigue or tiredness

Adult check-in
2021-09-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-09-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Itching · None

Adult check-in
2021-09-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Muscle or body aches

Adult check-in
2021-09-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-09-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-09-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-09-30
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-10-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-10-14
Survey response — day 21, dose 2
MedDRA: Headache — Feeling: Fair

Free text: Headache

MedDRA releases: 2024-11 · check-in free text available
2021-10-21
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-10-30
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-11-04
Survey response — day 42, dose 2
MedDRA: Cough, Headache — Feeling: Fair

Free text: Headache & cough

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Survey response — 3 months, dose 2
MedDRA: Cough, Fatigue, Lethargy, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school

Free text: Fatigue, lethargy, stuffy nose, cough, sore throat. Negative COVID test.

MedDRA releases: 2024-11 · check-in free text available
2022-03-24
Survey response — 6 months, dose 2
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school

Free text: COVID positive

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-31	Pfizer-BioNTech	Do not remember
2	2021-09-23	Pfizer-BioNTech	Do not remember

Free text

Release 10 — day 21, dose 2

2021-10-14

Symptoms: Headache

Release 10 — day 42, dose 2

2021-11-04

Symptoms: Headache & cough

Release 10 — 3 months, dose 2

2021-12-23

Symptoms: Fatigue, lethargy, stuffy nose, cough, sore throat. Negative COVID test.

Release 11 — 6 months, dose 2

2022-03-24

Symptoms: COVID positive

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Lethargy	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release